A systematic review of non-cardiac implantable electronic devices malfunctions in radiation therapy
Abstract
Purpose: The number of patients carrying implantable devices (IEDs) in radiotherapy is increasing. While the effects of radiation on cardiac IEDs are well documented, little has been written on non-cardiac IED (NC-IED). This study aims to collect and analyze current evidence on the effects of ionizing radiation on NC-IEDs.
Methods: A systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A literature search (January 2003-June 2025) was performed across four databases, focusing on cochlear implants, implantable pumps, and neurostimulators exposed to radiation. Reported malfunctions were analyzed according to device type, irradiation conditions (primary vs. scattered radiation), beam energy (neutron- vs. non-neutron-producing), and dose. Fisher's exact test was used to assess correlations between these parameters and device malfunctions. Authors' and manufacturers' recommendations for managing patients with NC-IEDs during radiotherapy were also collected.
Results: Twenty-seven articles were identified, mostly case reports (16). 184 devices were irradiated, with 27% exposed to the primary beam (mainly in vitro studies) and 73% to scattered radiation (all in vivo). Overall rate of malfunctions was 5.4% (10 NC-IEDs): 4.9% under the primary beam and 0.5% under scattered radiation (p 0.01). Manufacturers warn that ionising radiation can damage the device and suggest avoiding direct irradiation.…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Preliminary Toxicity Analysis of 3DCRT versus IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial
- Adaptive Radiotherapy for Head and Neck Cancer: Initial Clinical Outcomes from a Prospective Trial
- American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology
- Motion Management Strategies and Technical Issues Associated with Stereotactic Body Radiotherapy of Thoracic and Upper Abdominal Tumors: A Review from NRG Oncology
- High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial
- Highly efficient training, refinement, and validation of a knowledge-based plan quality control system for radiotherapy clinical trials
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.